• Cost-effectiveness of live oral attenuated human rotavirus vaccine in Tanzania 

      Ruhago, George M.; Ngalesoni, Frida Namnyak; Robberstad, Bjarne; Norheim, Ole Frithjof (Peer reviewed; Journal article, 2015-04-28)
      Background. Globally, diarrhoea is the second leading cause of morbidity and mortality, responsible for the annual loss of about 10% of the total global childhood disease burden. In Tanzania, Rotavirus infection is the ...
    • Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants 

      Rongsen-Chandola, Temsunaro; Strand, Tor A.; Goyal, Nidhi; Flem, Elmira; Singh Rathore, Sudeep; Arya, Alok; Winje, Brita Askeland; Lazarus, Robin; Shanmugasundaram, Elango; Babji, Sudhir; Sommerfelt, Halvor; Vainio, Kirsti; Kang, Gagandeep; Bhandari, Nita (Peer reviewed; Journal article, 2014-08-11)
      Interference from transplacental and breast milk antibodies may impede the performance of oral livevaccines. The effect of breastfeeding on the immunogenicity of Rotarix®, a two-dose oral monova-lent rotavirus vaccine, was ...
    • Making common sense of vaccines: an example of discussing the recombinant attenuated salmonella vaccine with the public 

      Dankel, Dorothy Jane; Roland, Kenneth L.; Fisher, Michael; Brenneman, Karen; Delgado Alemán, Ana; Santander, Javier; Baek, Chang-Ho; Clark-Curtiss, Josephine; Strand, Roger; Curtiss, Roy III (Journal article; Peer reviewed, 2014-07-10)
      Researchers have iterated that the future of synthetic biology and biotechnology lies in novel consumer applications of crossing biology with engineering. However, if the new biology’s future is to be sustainable, early ...